[1] Cardoso AC, Carvalho-Filho RJ, Stern C, et al. Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C. Liver Int, 2012. 32: 612-621.
[2] Afdhal NH, Bacon BR, Patel K, et al. Accuracy of fibroscan, compared with histology, in analysis of liver fibrosis in patients with hepatitis B or C: a United States multicenter study. Clin Gastroenterol Hepatol, 2015, 13: 772-779.
[3] Tapper EB, Cohen EB, Patel K, et al. Levels of Alanine Aminotransferase Confound Use of Transient Elastography to Diagnose Fibrosis in Patients With Chronic Hepatitis C Virus Infection. Clin Gastroenterol Hepatol, 2012, 10: 932-937.
[4] Arase Y, Suzuki F, Suzuki Y, et al. Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C. Hepatology, 2009, 49: 739-744.
[5] de Ledinghen V, Vergniol J, Foucher J, et al. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography. Liver Int, 2012, 32: p. 911-8.
[6] Alkhouri N, Sedki E, Alisi A, et al. Combined paediatric NAFLD fibrosis index and transient elastography to predict clinically significant fibrosis in children with fatty liver disease. Liver Int, 2013, 33: p. 79-85.
[7] Kwok R, Choi KC, Wong GL, et al. Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study. Gut, 2015, pii: gutijnl-2015-309265.
[8] Masuzaki R, Tateishi R, Yoshida H, et al. Risk Assessment of Hepatocellular Carcinoma in Chronic Hepatitis C Patients by Transient Elastography.J Clin Gastroenterol, 2008, 42:839-43.
[9] Kuo Y, Lu SN, Hung CH, et al. Liver stiffness measurement in the risk assessment of hepatocellular carcinoma for patients with chronic hepatitis. Hepatol Int, 2010, 4: 700-706.
[10] Feier D, Lupsor Platon M, Stefanescu H, et al. Transient elastography for the detection of hepatocellular carcinoma in viral C liver cirrhosis. Is there something else than increased liver stiffness. J Gastrointestin Liver Dis, 2013, 22: 283-289.
[11] Graham CS, Baden LR, Yu E, et al. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis, 2001, 33: 562-569.
[12] Sánchez-Conde M, Montes-Ramírez ML, Miralles P, et al. Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers. J Viral Hepat, 2010, 17: 280-286.
[13] Sagir A, Glaubach B, Sahin K, et al. Transient Elastography for the Detection of Liver Damage in Patients with HIV. Infect Dis Ther, 2015, 4:355-364.
[14] Bureau C, Metivier S, Peron JM, et al. Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease. Alimentary Pharmacol Ther, 2008, 27: 1261-1268.
[15] Al-Hamoudi WK, Abdelrahman AA, Helmy A, et al. The role of Fibroscan in predicting the presence of varices in patients with cirrhosis. Eur J Gastroenterol Hepatol, 2015, 27:1307-1312.
[16] Hu Z, Li Y, Li C, et al. Using Ultrasonic Transient Elastometry (FibroScan) to Predict Esophageal Varices in Patients with Viral Liver Cirrhosis. Ultrasound Med Biol, 2015, 41: 1530-1537.
[17] Cescon M, Cucchetti A, Colecchia A, et al. Value of Transient Elastography Measured With Fibroscan in Predicting the Outcome of Hepatic Resection for Hepatocellular Carcinoma. Ann Surg, 2012, 256: 706-713.
[18] Li C, Zhang JY, Zhang XY, et al. FibroScan predicts ascites after liver resection for hepatitis B virus-related hepatocellular carcinoma: A prospective cohort study. Int J Surg, 2015, 20: 21-25.
[19] Singh S, Fujii LL, Murad MH, et al. Liver Stiffness Is Associated With Risk of Decompensation, Liver Cancer, and Death in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol, 2013, 11: 1573-1584.
[20] Bae RC, Cho HJ, Oh JT, Lee EK, et al. [Clinical factors influencing liver stiffness as measured by transient elastography (Fibroscan) in patients with chronic liver disease]. Korean J Hepatol, 2010, 16: 123-130.
[21] Arena U, Vizzutti F, Abraldes JG, et al. Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C. Gut, 2008, 57: 1288-1293.
[22] Chan HLY, Wong GL, Choi PC, et al. Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B. J Viral Hepat, 2009, 16: 36-44.
[23] Taylor-Robinson SD, Cobbold JFL, Thomas HC. Liver stiffness measurements in acute hepatitis B: implications for clinical practice. Euro J Gastroenterol Hepatol, 2010, 22: 133-134.
[24] Lee DM, Moon EJ, Hwang JA, et al. Factors associated with liver stiffness in chronic liver disease. Korean J Hepatol, 2009, 15: 464.
[25] Viganò M, Massironi S, Lampertico P, et al. Transient elastography assessment of the liver stiffness dynamics during acute hepatitis B. Euro J Gastroenterol Hepatol, 2010, 22: 180-184.
[26] Sagir A, Erhardt A, Schmitt M, et al. Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology, 2008, 47: 592-595.
[27] Wong GL, Wong VW, Choi PC, et al. Increased liver stiffness measurement by transient elastography in severe acute exacerbation of chronic hepatitis B. J Gastroenterol Hepatol, 2009, 24: 1002-1007.
[28] Arena U, Vizzutti F, Corti G, et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology, 2008, 47: 380-384.
[29] Fung J, Lai CL, But D, et al. Reduction of liver stiffness following resolution of acute flares of chronic hepatitis B. Hepatol Int, 2010, 4: 716-722.
[30] Coco B, Oliveri F, Maina AM, et al. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat, 2007, 14: 360-369.
[31] Oliveri F, Coco B, Ciccorossi P, et al. Liver stiffness in the hepatitis B virus carrier: A non-invasive marker of liver disease influenced by the pattern of transaminases. World J Gastroenterol, 2008, 14: 6154.
[32] Park H, Kim SU, Kim D, et al. Optimal Time for Restoring the Reliability of Liver Stiffness Measurement in Patients With Chronic Hepatitis B Experiencing Acute Exacerbation.J Clin Gastroenterol, 2012, 46:602-607.
[33] Millonig G, Reimann FM, Friedrich S, et al. Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis. Hepatology, 2008, 48: 1718-1723.
[34] Hopper I, Kemp W, Porapakkham P, et al. Impact of heart failure and changes to volume status on liver stiffness: non-invasive assessment using transient elastography. Euro J Heart Failure, 2012, 14: 621-627.
[35] Millonig G, Friedrich S, Adolf S, et al. Liver stiffness is directly influenced by central venous pressure. J Hepatol, 2010, 52: 206-210.
[36] de Lédinghen V, Wong VW, Vergniol J, et al. Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: Comparison between M and XL probe of FibroScan?.J Hepatol, 2012, 56:833-839. |
